Indications, contraindications and limitations of endoscopic therapy for Barrett’s esophagus and early esophageal adenocarcinoma
Endoscopic eradication therapy (EET) has revolutionized management of Barrett’s esophagus (BE)-associated neoplasia, traditionally treated by esophagectomy, which carries very high mortality and morbidity. EET, usually performed in the outpatient setting, has a safe risk profile. It is indicated in...
Main Authors: | Carol Rouphael, Mythri Anil Kumar, Madhusudhan R. Sanaka, Prashanthi N. Thota |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-05-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756284820924209 |
Similar Items
-
Chemoprevention in Barrett’s esophagus and esophageal adenocarcinoma
by: Motasem Alkhayyat, et al.
Published: (2021-08-01) -
The Efficacy of Linked Color Imaging in the Endoscopic Diagnosis of Barrett’s Esophagus and Esophageal Adenocarcinoma
by: Mamoru Tokunaga, et al.
Published: (2020-01-01) -
Identification of a key role of widespread epigenetic drift in Barrett’s esophagus and esophageal adenocarcinoma
by: E. Georg Luebeck, et al.
Published: (2017-10-01) -
Esophageal microbiome signature in patients with Barrett's esophagus and esophageal adenocarcinoma.
by: Loris Riccardo Lopetuso, et al.
Published: (2020-01-01) -
Barrett’s esophagus: novel strategies for screening and surveillance
by: Vedha Sanghi, et al.
Published: (2019-03-01)